Last reviewed · How we verify
QazCovid-in®-vaccine against COVID-19
QazCovid-in®-vaccine against COVID-19 is a Biologic drug developed by Research Institute for Biological Safety Problems. It is currently in Phase 3 development for Prevention of COVID-19 disease.
QazCovid-in stimulates an immune response to provide protection against COVID-19.
QazCovid-in stimulates an immune response to provide protection against COVID-19. Used for Prevention of COVID-19 disease.
At a glance
| Generic name | QazCovid-in®-vaccine against COVID-19 |
|---|---|
| Sponsor | Research Institute for Biological Safety Problems |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
QazCovid-in is a vaccine that works by introducing a piece of genetic material from the SARS-CoV-2 virus to the body, which triggers an immune response and helps the body produce antibodies to fight the virus. This immune response provides protection against COVID-19.
Approved indications
- Prevention of COVID-19 disease
Common side effects
- Pain, redness, or swelling at the injection site
- Fatigue
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- QazCovid-in®-vaccine against COVID-19 CI brief — competitive landscape report
- QazCovid-in®-vaccine against COVID-19 updates RSS · CI watch RSS
- Research Institute for Biological Safety Problems portfolio CI
Frequently asked questions about QazCovid-in®-vaccine against COVID-19
What is QazCovid-in®-vaccine against COVID-19?
How does QazCovid-in®-vaccine against COVID-19 work?
What is QazCovid-in®-vaccine against COVID-19 used for?
Who makes QazCovid-in®-vaccine against COVID-19?
What development phase is QazCovid-in®-vaccine against COVID-19 in?
What are the side effects of QazCovid-in®-vaccine against COVID-19?
Related
- Manufacturer: Research Institute for Biological Safety Problems — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Prevention of COVID-19 disease
- Compare: QazCovid-in®-vaccine against COVID-19 vs similar drugs
- Pricing: QazCovid-in®-vaccine against COVID-19 cost, discount & access